Tenpoint Therapeutics and Visus Therapeutics have merged to focus on aging-related ocular conditions, with key products ...

VisiRose, a company formed in collaboration with Provectus Biopharmaceuticals and the University of Miami Miller School of ...

EXG102 and EXG202 are investigational gene therapy candidates for wet age-related macular degeneration that are in ...

Bausch + Lomb announced the acquisition of the ELIOS system, a laser-based technology that offers a new approach to treating ...

Confocal color imaging, green autofluorescence, and OCT are preferred for GA evaluation, each with unique benefits and ...

According to the partners, glaucoma research to be led by internationally renowned glaucoma surgeon Ike Ahmed, MD, FRCSC, ...

Nona Biosciences has partnered with Kodiak Sciences to develop multi-target antibodies for ophthalmic diseases. Utilizing ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

In an interview with Ophthalmology Times, Alon Kahana, MD, PhD, discusses interleukin-6 and its role in autoimmune diseases, particularly thyroid eye disease, noting that a promising alternative under ...

It is noteworthy that patients with mild TBI often report visual issues despite normal results of visual acuity measurements ...

The authors searched PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports ...

According to researchers, GPT-4o demonstrates potential in generating comprehensive differential glaucoma diagnoses but falls ...